Pakistani pharmaceutical company secures second WHO prequali

WHO prequalification involves a detailed assessment of manufacturing practices, quality management systems and compliance with internationally recognised standards. A Pakistani pharmaceutical manufacturer has secured a second prequalification from the World Health Organisation (WHO) for its manufacturing facility, marking another development in the country's efforts to meet international pharmaceutical production standards. WHO prequalification involves a detailed assessment of manufacturing practices, quality management systems and compliance with internationally recognised standards. The process is designed to ensure that pharmaceutical products and manufacturing facilities meet the quality, safety and efficacy requirements necessary for international procurement. The latest recognition could strengthen the company's position in international pharmaceutical markets, particularly where compliance with WHO standards is an important requirement for supplying medicines to global health programmes. WHO prequalification is also relevant to procurement by United Nations agencies and other international organisations involved in distributing medicines to developing countries. For Pakistan's pharmaceutical industry, such approvals are important in expanding access to regulated export markets and improving the international competitiveness of locally manufactured medicines. The recognition comes as Pakistani pharmaceutical companies seek to expand exports and strengthen compliance with international manufacturing and quality standards.